Here's a more complete picture of Apellis' executive compensation

The prospectus for Apellis Pharmaceutical's second public stock offering fills in more details for the executive compensation packages of its named officers. I reported recently about the Apellis board of directors approving the 2018 salaries and bonuses for Apellis' four named officers, as disclosed in filings with U.S. Securities and Exchange Commission. Earlier filings show only the officers' compensation for 2016. The prospectus for Apellis' $1 25 million common stock offering shows what…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news